Loading
IARC estimates 18,655 new cancer cases and 12,047 cancer deaths in Chad in 2024; the commonest new cancers are prostate, breast and cervix uteri. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Prostate | 3,340 | 97.9 | Prostate cancer |
| Breast | 3,103 | 50.4 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 2,348 | 38.1 | Cervical cancer |
| Liver and intrahepatic bile ducts | 2,064 | 20.9 | Hepatocellular carcinoma |
| Non-Hodgkin lymphoma | 679 | 4.7 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Bladder | 654 | 6.5 | Bladder & urothelial cancer |
| Colorectum | 488 | 4.4 | Colorectal cancer |
| Stomach | 481 | 4.7 | Gastric & gastro-oesophageal junction cancer |
| Thyroid | 414 | 3.8 | Thyroid cancer |
| Pancreas | 353 | 4.2 | Pancreatic ductal adenocarcinoma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Prostate | 2,046 | 59.9 | Prostate cancer |
| Liver and intrahepatic bile ducts | 1,821 | 19.1 | Hepatocellular carcinoma |
| Breast | 1,415 | 24.2 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 1,337 | 22.3 | Cervical cancer |
| Pancreas | 331 | 4.0 | Pancreatic ductal adenocarcinoma |
| Non-Hodgkin lymphoma | 327 | 2.5 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Stomach | 325 | 3.5 | Gastric & gastro-oesophageal junction cancer |
| Bladder | 314 | 3.6 | Bladder & urothelial cancer |
| Colorectum | 241 | 2.4 | Colorectal cancer |
| Oesophagus | 235 | 2.3 | Oesophageal cancer |
No trial record in OnCo lists a site in Chad. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Chad.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Chad is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Chad is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.